Pharmaceutical Technology Europe-11-01-2011

i1-746096-1408611165802.jpg

Pharmaceutical Technology Europe

June and July saw three major US conferences on implementing single-use technologies: the IBC Single-use Applications meeting, the PDA Single-use Workshop and the Bio-Process Systems Alliance (BPSA) International Single-use Summit (ISUS). Jerold Martin highlights some of the key topics discussed at these meetings.

i1-746101-1408611158406.jpg

Pharmaceutical Technology Europe

Counterfeit medicines are an increasing threat to the EU supply chain and there is need for a standard identification solution across Europe.

i1-746097-1408611164119.jpg

Pharmaceutical Technology Europe

The middle word in our magazine's title is technology, so I cannot fail to join the increasing numbers of people in all fields of business commenting on the passing of Steve Jobs.

i1-746100-1408611160004.jpg

Pharmaceutical Technology Europe

Counterfeiting continues to be a huge challenge affecting both branded and generic products, which, although a worldwide issue, is especially prominent in developing countries.

News

Pharmaceutical Technology Europe

EC wants clear rules for medicines information

i1-746099-1408611161402.jpg

Pharmaceutical Technology Europe

Continuous manufacturing is increasingly noted as an important long-term objective for the pharmaceutical industry. PTE talks with Tim Freeman, Director of Operations at Freeman Technology, about some of the central issues involved in this transition, as well as the supporting role of relevant analytical technology.

Pharmaceutical Technology Europe

In an age dominated by the internet and uncertainty over the best packaging security methods to employ, counterfeit medicines have the ideal environment to thrive.

lj-745639-1408611599880.gif

Pharmaceutical Technology Europe

PTE interviews Leigh Jordan, UK Sales Manager at Cognex UK Ltd, about the importance of code readability when using anticounterfeiting solutions such as 2D datamatrix codes.

fj-744837-1408612247987.gif

Pharmaceutical Technology Europe

Dr. Fred Jordan, CEO at AlpVision SA, explains how web-based server solutions can aid anticounterfeiting strategies and why such systems are seeing increased uptake.